Testing effectiveness (Phase 2)Ended earlyNCT02991898
What this trial is testing
Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies
Who this might be right for
Acute Lymphoblastic LeukemiaBurkitt LymphomaNatural Killer Cell Malignancies+15 more
Masonic Cancer Center, University of Minnesota 3